Mosser David M, Zhang Xia
Department of Cell Biology and Molecular Genetics, The Maryland Pathogen Research Institute, University of Maryland, College Park, Maryland.
Curr Protoc Immunol. 2008 Nov;Chapter 14:14.2.1-14.2.8. doi: 10.1002/0471142735.im1402s83.
Our understanding of cell mediated immunity (CMI) has revealed the importance of activated macrophages as key immune effector cells. Over the past decade, we have come to realize that macrophages exhibit remarkable plasticity, and different populations of macrophages with distinct physiologies can develop in response to different stimuli. In fact, it is likely that the number of different macrophage populations that can arise may be as diverse as the activating stimuli that induce them. Some of these stimuli can instruct macrophages to kill microbes (classical activation), lay down extracellular matrix components to promote wound healing (alternative activation), or secrete anti-inflammatory cytokines to terminate inflammation (regulatory macrophages). New ways to biochemically identify these cells have led to a better understanding of the heterogeneity of activated macrophages. As our understanding of the various macrophage populations increases, so does the potential for therapeutic intervention based on targeting specific populations of activated macrophages.
我们对细胞介导免疫(CMI)的理解揭示了活化巨噬细胞作为关键免疫效应细胞的重要性。在过去十年中,我们逐渐认识到巨噬细胞具有显著的可塑性,并且不同生理状态的巨噬细胞群体可因不同刺激而产生。事实上,可能产生的不同巨噬细胞群体的数量与诱导它们的激活刺激一样多样。其中一些刺激可指导巨噬细胞杀死微生物(经典激活)、分泌细胞外基质成分以促进伤口愈合(替代激活)或分泌抗炎细胞因子以终止炎症(调节性巨噬细胞)。生化鉴定这些细胞的新方法使我们对活化巨噬细胞的异质性有了更好的理解。随着我们对各种巨噬细胞群体的了解不断增加,基于靶向特定活化巨噬细胞群体进行治疗干预的潜力也在增加。